According to the data of the Administration, about 654.38 million Americans are currently taking Nometine, 80% of whom are middle-aged women. The average time for users to take the drug is 50 days, and the average weight loss is 5 pounds (about 2.3 kilograms). Experts from the bureau believe that the "slimming effect" of consumers taking this diet medicine is very limited. Considering the health risks of this drug, health should not be sacrificed under two measures. Health Canada said earlier on the 8th that Abbott would voluntarily stop selling Nometine in Canada. Since 1997 was approved for global marketing, it has been sold in the United States and Canada for more than 10 years.